In the assessment of 12-month price targets, analysts unveil insights for DexCom, presenting an average target of $98.44, a ...

The CGM market is practically a duopoly that DexCom shares with Abbott Laboratories. DexCom's success in this market explains ...

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company ...

DexCom is a leader in the continuous glucose ... However, CGMs are, in many ways, superior to their alternatives, blood glucose meters (BGMs). CGMs automatically take measurements throughout ...

Investing.com -- DexCom Inc (NASDAQ:DXCM) shares up more than 2% following updated guidelines by the American Diabetes Association (ADA), which now recommend using continuous glucose monitors ...

Although excellent medical care is always in high demand, the healthcare sector continuously evolves. Let's consider two that ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by ...

Smart ring maker Oura announced on Tuesday that it has received a $75 million investment from glucose device maker Dexcom. The investment marks Oura’s Series D funding round and brings the ...